These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Epidemiology of microsatellite instability across solid neoplasms]. Colle R; Cohen R Bull Cancer; 2019 Feb; 106(2):114-118. PubMed ID: 30409467 [TBL] [Abstract][Full Text] [Related]
4. Polymerase proofreading domain mutations: New opportunities for immunotherapy in hypermutated colorectal cancer beyond MMR deficiency. Bourdais R; Rousseau B; Pujals A; Boussion H; Joly C; Guillemin A; Baumgaertner I; Neuzillet C; Tournigand C Crit Rev Oncol Hematol; 2017 May; 113():242-248. PubMed ID: 28427513 [TBL] [Abstract][Full Text] [Related]
5. [Clinical and molecular consequences of microsatellite instability in human cancers]. Hamelin R; Chalastanis A; Colas C; El Bchiri J; Mercier D; Schreurs AS; Simon V; Svrcek M; Zaanan A; Borie C; Buhard O; Capel E; Zouali H; Praz F; Muleris M; Fléjou JF; Duval A Bull Cancer; 2008 Jan; 95(1):121-32. PubMed ID: 18230578 [TBL] [Abstract][Full Text] [Related]
6. Immune Microenvironment in Microsatellite-Instable Endometrial Cancers: Hereditary or Sporadic Origin Matters. Pakish JB; Zhang Q; Chen Z; Liang H; Chisholm GB; Yuan Y; Mok SC; Broaddus RR; Lu KH; Yates MS Clin Cancer Res; 2017 Aug; 23(15):4473-4481. PubMed ID: 28264871 [No Abstract] [Full Text] [Related]
7. Low frequency of mismatch repair deficiency in gallbladder cancer. Goeppert B; Roessler S; Renner M; Loeffler M; Singer S; Rausch M; Albrecht T; Mehrabi A; Vogel MN; Pathil A; Czink E; Köhler B; Springfeld C; Rupp C; Weiss KH; Schirmacher P; von Knebel Doeberitz M; Kloor M Diagn Pathol; 2019 May; 14(1):36. PubMed ID: 31068195 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents. Bodo S; Colas C; Buhard O; Collura A; Tinat J; Lavoine N; Guilloux A; Chalastanis A; Lafitte P; Coulet F; Buisine MP; Ilencikova D; Ruiz-Ponte C; Kinzel M; Grandjouan S; Brems H; Lejeune S; Blanché H; Wang Q; Caron O; Cabaret O; Svrcek M; Vidaud D; Parfait B; Verloes A; Knappe UJ; Soubrier F; Mortemousque I; Leis A; Auclair-Perrossier J; Frébourg T; Fléjou JF; Entz-Werle N; Leclerc J; Malka D; Cohen-Haguenauer O; Goldberg Y; Gerdes AM; Fedhila F; Mathieu-Dramard M; Hamelin R; Wafaa B; Gauthier-Villars M; Bourdeaut F; Sheridan E; Vasen H; Brugières L; Wimmer K; Muleris M; Duval A; Gastroenterology; 2015 Oct; 149(4):1017-29.e3. PubMed ID: 26116798 [TBL] [Abstract][Full Text] [Related]
9. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications. Marginean EC; Melosky B Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791 [TBL] [Abstract][Full Text] [Related]
10. The Significance of Mismatch Repair Deficiency in Young Patients With Endometrial Cancer. Chu MM; Liu SS; Tam KF; Ip PP; Cheung AN; Ngan HY Int J Gynecol Pathol; 2015 Sep; 34(5):403-10. PubMed ID: 26262451 [TBL] [Abstract][Full Text] [Related]
11. Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics. Imai K; Yamamoto H Carcinogenesis; 2008 Apr; 29(4):673-80. PubMed ID: 17942460 [TBL] [Abstract][Full Text] [Related]
12. Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer. Vilar E; Mork ME; Cuddy A; Borras E; Bannon SA; Taggart MW; Ying J; Broaddus RR; Luthra R; Rodriguez-Bigas MA; Lynch PM; You YQ Cancer Genet; 2014; 207(10-12):495-502. PubMed ID: 25432668 [TBL] [Abstract][Full Text] [Related]
13. A gene expression assay for simultaneous measurement of microsatellite instability and anti-tumor immune activity. Danaher P; Warren S; Ong S; Elliott N; Cesano A; Ferree S J Immunother Cancer; 2019 Jan; 7(1):15. PubMed ID: 30665466 [TBL] [Abstract][Full Text] [Related]
14. Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas. McConechy MK; Talhouk A; Li-Chang HH; Leung S; Huntsman DG; Gilks CB; McAlpine JN Gynecol Oncol; 2015 May; 137(2):306-10. PubMed ID: 25636458 [TBL] [Abstract][Full Text] [Related]
15. Immunotherapy holds the key to cancer treatment and prevention in constitutional mismatch repair deficiency (CMMRD) syndrome. Westdorp H; Kolders S; Hoogerbrugge N; de Vries IJM; Jongmans MCJ; Schreibelt G Cancer Lett; 2017 Sep; 403():159-164. PubMed ID: 28645564 [TBL] [Abstract][Full Text] [Related]
16. Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors. Mensenkamp AR; Vogelaar IP; van Zelst-Stams WA; Goossens M; Ouchene H; Hendriks-Cornelissen SJ; Kwint MP; Hoogerbrugge N; Nagtegaal ID; Ligtenberg MJ Gastroenterology; 2014 Mar; 146(3):643-646.e8. PubMed ID: 24333619 [TBL] [Abstract][Full Text] [Related]
17. Mismatch repair deficiency: The what, how and why it is important. Olave MC; Graham RP Genes Chromosomes Cancer; 2022 Jun; 61(6):314-321. PubMed ID: 34837268 [TBL] [Abstract][Full Text] [Related]
18. The evolving role of microsatellite instability in colorectal cancer: A review. Gelsomino F; Barbolini M; Spallanzani A; Pugliese G; Cascinu S Cancer Treat Rev; 2016 Dec; 51():19-26. PubMed ID: 27838401 [TBL] [Abstract][Full Text] [Related]
19. Molecular testing for microsatellite instability and DNA mismatch repair defects in hereditary and sporadic colorectal cancers--ready for prime time? Søreide K Tumour Biol; 2007; 28(5):290-300. PubMed ID: 17962726 [TBL] [Abstract][Full Text] [Related]
20. Microsatellite instability as a predictive factor for immunotherapy in malignant melanoma. Kubecek O; Trojanova P; Molnarova V; Kopecky J Med Hypotheses; 2016 Aug; 93():74-6. PubMed ID: 27372860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]